{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:14:36Z","timestamp":1792095276158,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":3470,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1111\/ajt.12209","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T12:15:31Z","timestamp":1366200931000},"page":"1601-1605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C"],"prefix":"10.1016","volume":"13","author":[{"given":"R.J.","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Appelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dimitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hindes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.T.","family":"Symonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.12209_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cld.2006.08.012","article-title":"Hepatitis C virus and liver transplantation","volume":"10","author":"Verna","year":"2006","journal-title":"Clin Liv Dis"},{"key":"10.1111\/ajt.12209_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12209_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/gast.1996.v110.pm8536853","article-title":"A longitudinal analysis of hepatitis C virus replication following liver transplantation","volume":"110","author":"Gane","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12209_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2036.2010.04505.x","article-title":"Systematic review: Anti-viral therapy of recurrent hepatitis C after liver transplantation","volume":"33","author":"Guillouche","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/ajt.12209_bib5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1053\/j.gastro.2012.01.030","article-title":"Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated Interferon","volume":"142","author":"Levitsky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12209_bib6","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hep.25831","article-title":"Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers","volume":"56","author":"Hulskotte","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12209_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24443","article-title":"Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus","volume":"54","author":"Garg","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1111\/ajt.12209_bib8","first-page":"A#9","article-title":"Efficacy and safety of protease inhibitors for hepatitis C recurrence after liver transplantation: A first multicentric experience (Abstract)","volume":"56","author":"Coilly","year":"2012","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1111\/ajt.12209_bib9","first-page":"A#10","article-title":"Preliminary experience using telaprevir with peginterferon and ribavirin for treatment of HCV genotype 1 after liver transplantation (Abstract)","volume":"56","author":"Pungapong","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12209_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa1104430","article-title":"Preliminary study of two oral antiviral agents for hepatitis C genotype 1","volume":"366","author":"Lok","year":"2012","journal-title":"NEJM"},{"key":"10.1111\/ajt.12209_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1473-3099(12)70138-X","article-title":"Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: A randomized, parallel-group, double-blind, placebo controlled, dose finding, phase 2a","volume":"12","author":"Pol","year":"2012","journal-title":"Trial Lancet Inf Dis"},{"key":"10.1111\/ajt.12209_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"NEJM"},{"issue":"Suppl 1","key":"10.1111\/ajt.12209_bib13","first-page":"230","article-title":"Once daily sofosbuvir (GS 7977) plus PEG\/RBV: High early response rates are maintained during post-treatment follow-up in treatment na\u00efve patient with HCV Genotype 1, 4 and 6 infection in the ATOMIC study (Abstract)","volume":"56","author":"Hassanein","year":"2012","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1111\/ajt.12209_bib14","first-page":"A #1340","article-title":"Daclatasvir (DCV; BMS-790052) has no clinically significant effect on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female subjects (Abstract)","volume":"54","author":"Bifano","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1111\/ajt.12209_bib15","first-page":"A1869","article-title":"NO clinically significant pharmacokinetic drug-drug interactions between Sofosbuvir (GS-7977) and the immunosuppressants cyclosporine A or Tacrolimus in health volunteers (Abstract)","volume":"56","author":"Mathias","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12209_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/lt.22175","article-title":"Post liver transplant cholestatic hepatitis C: AA systematic review of clinical and pathological findings and application of consensus criteria","volume":"16","author":"Narang","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12209_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2010.11.012","article-title":"Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients","volume":"55","author":"Selzner","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12209_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2006.10.017","article-title":"Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation","volume":"46","author":"Picciotto","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12209_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-6143.2008.02362.x","article-title":"Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent HCV infection","volume":"8","author":"Veldt","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1111\/ajt.12209_bib20","first-page":"LB#2","article-title":"High rate of sustained virological response with all-oral combination of daclatasvir (NS5A inhibitor) plus sofosbuvir (nucleotide NS5B inhibitor), +\/\u2212 ribavirin, in treatment na\u00efve patients with chronically infected with HCV genotype 1, 2 and 3 (Abstract)","volume":"56","author":"Sulkowski","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12209_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(13)61204-0","article-title":"Safety profile of Daclatasvir in combination with peginterferon alfa and ribavirin in 1100 patients with chronic HCV infection treated in Phase 2 studies","author":"Jacobson","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12209_bib22","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1016\/S0168-8278(12)61132-5","article-title":"GS 0-7977 400 mg q d safety and tolerability in the over 500 patients treated for at least 12 weeks (Abstract)","volume":"56","author":"Jacobson","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12209_bib23","doi-asserted-by":"crossref","first-page":"S431","DOI":"10.1016\/S0168-8278(12)61113-1","article-title":"The effect of renal impairment and end stage renal disease on the single-dose pharmacokinetics of PSI-7977","volume":"56","author":"Cornpropst","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12209_bib24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/lt.23482","article-title":"Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver Retransplantation","volume":"18","author":"Hughes","year":"2012","journal-title":"Liver Transpl"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12209","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522259887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522259887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:59:19Z","timestamp":1761627559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522259887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1600613522259887"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12209","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}